Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

University of California - Irvine Medical Center, Irvine, California, United States

University of Florida (UF) - Gainesville, Gainesville, Florida, United States

Emory University Hospital, Atlanta, Georgia, United States

Washington University in St. Louis, St Louis, Missouri, United States

Duke University Medical Center, Durham, North Carolina, United States

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

University of Pennsylvania, Philadelphia, Pennsylvania, United States

University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States

Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), Fairfax, Virginia, United States

UZ Leuven, Leuven, Belgium

Aarhus University Hospital, Aarhus, Denmark

HLC Hopital Pierre Wertheimer, Bron, France

AP-HP Hopital Raymond Poincare, Garches, France

Centre de Reference des Maladies Neuromusculaires et de la SLA - AP-HM Hopital de La Timone, Marseille, France

CHU de Nice - Hopital Pasteur 2 - Centre de reference des Maladies Neuromusculaires, Nice, France

Universitaetsklinikum Halle (Saale), Halle, Germany

SphinCS GmbH, Höchheim, Germany

Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München, Germany

A.O.U. Policlinico "G. Martino", Messina, Italy

AOU Citta della Salute e della Scienza di Torino - Ospedale le Molinette, Torino, Italy

Erasmus MC, GE Rotterdam, GE Rotterdam, Netherlands

Hospital Universitario 12 de Octubre, Madrid, Spain

Hospital Universitari i Politecnic La Fe, Valencia, Spain

Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom

National Hospital for Neurology & Neurosurgery, London, United Kingdom

Royal Free London NHS Foundation Trust, London, United Kingdom

Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom

Salford Royal Hospital, Salford, United Kingdom